Oxford Drug Design headquarters details
- Street address
- 36-37 Pembroke Street
- City
- Oxford
- State / region
- England
- ZIP / postal code
- OX1 1BP
- Country
- United Kingdom
- Phone
- +44 1865 261471
- Founded
- 2001
- Website
- oxforddrugdesign.com
Location map
Open in Google MapsAll Oxford Drug Design office locations
| City | State / region | Country | Type |
|---|---|---|---|
| Oxford HQ | England | United Kingdom | Headquarters |
Showing the headquarters of 3 recorded locations. See every location in GraphIQ →
About Oxford Drug Design
Oxford Drug Design is headquartered in Oxford, England, United Kingdom. Founded in 2001, the company has 3 recorded locations and employs approximately 12 people worldwide.
Where is Oxford Drug Design's main office?
Oxford Drug Design's main headquarters office is located at 36-37 Pembroke Street, Oxford, England OX1 1BP, United Kingdom. This is the company's primary corporate address.
Oxford Drug Design contact information
The main switchboard for Oxford Drug Design headquarters can be reached at +44 1865 261471. Official website: oxforddrugdesign.com.
What does Oxford Drug Design do?
Oxford Drug Design focuses on developing and delivering services and technologies in computer-aided drug discovery.
Frequently asked questions
Where is Oxford Drug Design headquarters?
Oxford Drug Design's headquarters is located at 36-37 Pembroke Street, Oxford, England OX1 1BP, United Kingdom.
How many offices does Oxford Drug Design have?
GraphIQ records 3 locations for Oxford Drug Design, as of October 2026.
What is Oxford Drug Design's corporate address?
The corporate headquarters address is 36-37 Pembroke Street, Oxford, England OX1 1BP, United Kingdom.
When was Oxford Drug Design founded?
Oxford Drug Design was founded in 2001 and employs approximately 12 people.
What is Oxford Drug Design's phone number?
The main phone number for Oxford Drug Design headquarters is +44 1865 261471.
How many employees does Oxford Drug Design have?
Oxford Drug Design has approximately 12 employees (GraphIQ estimate, 2026).